CAS 5834-63-9
:1,8,15,22-tétraazacyclooctacosane-2,9,16,23-tétrone
- 1,8,15,22-Tetraazacyclooctacosane-2,9,16,23-tetrone
1,8,15,22-tetrazacyclooctacosane-2,9,16,23-tetrone
CAS :Formule :C24H44N4O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :452.63061,8,15,22-Tetraazacyclononacosane-2,9,16,23-tetrone
CAS :Produit contrôléApplications 1,8,15,22-Tetraazacyclononacosane-2,9,16,23-tetrone is used in biological study as a metabolite of Corynebacterium Aurantiacum.
References Fukumura, T. et al.: Jou. of Fer. Tec., 60(5), 469-72, (1982)Formule :C24H44N4O4Couleur et forme :NeatMasse moléculaire :452.6311,8,15,22-Tetraazacyclononacosane-2,9,16,23-tetrone
CAS :1,8,15,22-Tetraazacyclononacosane-2,9,16,23-tetrone is a potent inhibitor of kinases that have been shown to be involved in the growth and survival of cancer cells. This compound was isolated from Chinese urine and has been found to induce apoptosis in cancer cells by inhibiting kinase activity. The analogs of this compound have been developed as anticancer agents due to their ability to inhibit cyclin-dependent kinases (CDKs) that are involved in cell cycle regulation. This inhibitor has shown promising results in preclinical studies for the treatment of various types of tumors, including breast cancer and lung cancer. It is a potential candidate for further development as an anticancer drug due to its high specificity towards human kinases and low toxicity towards healthy cells.
Formule :C24H44N4O4Degré de pureté :Min. 95%Masse moléculaire :452.6 g/mol



